Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
malabsorption
mestinon
myasthenia gravis
myasthenia gravis, anticholinesterase malabsorption in
myasthenia gravis, anticholinesterase serum levels in
Showing articles 0 to 50 of 3322 Next >>

Plasma Pyridostigmine Levels in Myasthenia Gravis
Neurol 31:145-150, White,M.C.,et al, 1981

Malabsorption of Pyridostigmine in Patients with Masthenia Gravis
Neurol 27:299, Cohan,S.L.,et al, 1977

Narcolepsy
NEJM 288:1156, Zarcone,V., 1973

Neurological Problems in Endocrine Diseases
Med Clin North Am 56:1029, Dale,A., 1972

A Child with Arthrogryposis
Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018

International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016

Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016

Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014

Myasthenia Gravis
BMJ 345:e8497, Spillane, J.,et al, 2012

Treatment of Ocular Symptoms in Myasthenia Gravis
Neurol 71:1335-1341, Bhanushali,M.J.,et al, 2008

Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007

Ocular Myasthenia Gravis Treatment: The Case Against Prednisone Therapy and Thymectomy
Arch Neurol 64:1790-1792,1794, Gilbert,M.E.,et al, 2007

Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006

Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004

Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003

A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002

Morvan's Fibrillary Chorea: A Paraneoplastic Manifestation of Thymoma
JNNP 65:857-862, Lee,E.K.,et al, 1998

Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997

Clinicopath Conf
Rocky Mountain Spotted Fever with Meningoencephalomyelitis, Vasculitis and Focal Myocarditis, Case 3, -17,NEJM 337:1149-1156,1997., 1997

Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994

Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994

Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991

Citrate-Induced Impairment of Neuromuscular Transmission in Human and Experimental Autoimmune Myasthenia Gravis
Ann Neurol 27:328-330, Wirguin,I.,et al, 1990

Memory Dysfunction in Myasthenia Gravis:Evidence for Central Cholinergic Effects
Neurol 38:1173-1177, Tucker,D.M.,et al, 1988

The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984

Left-handedness:Association with Immune Disease, Migraine, & Developmental Learning Disorder
Proc Natl Acad Sci 79:5097-5100, Geschwind,N.,et al, 1982

Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980

Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice
Neurol 104:e213498, Zara,P.,et al, 2025

The "Chameleon Eyes Sign" in Myasthenia Gravis
Neurol 103:e209756, Zara,P.,et al, 2024

Clinicopathologic Conference, Legionella Infection Complicated by Rhabdomyolysis
NEJM 391:1039-1048, Case 29-2024, 2024

Clinicopathologic Conference, Myasthenia Gravis
NEJM 391:1441-1450, Case 32-2024, 2024

Clinicopathologic Conference, Brain Abscess Due to Infection with Listeria Monocytogeneses
NEJM 391:1529-1538, Case 33-2024, 2024

Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology
Ann Neurol 96:1020-1025, Falso,S.,et al, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Ocular Myasthenia Gravis, Central Ocular Motor Signs and Unilateral Visual Loss Caused by the Great Neuro-Ophthalmologic Impersonator
Neurol 102:e209260, Young,A. & Johnston,J.L., 2024

Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024

Clinicopathologic Conference, Antiphospholipid Syndrome due to SLE with Hypocomplimentemia
NEJM 389: 2277-2285, Case 38-2023, 2023

Hyperglycemia-Induced Occipital Lobe Seizures
Neurol 101:e852-e853, Bessemer,R.A.,et al, 2023

Clinicopathologic Conference, Noncirrhotic hyperammonemia after Roux-en-Y Gastric Bypass
NEJM 389:1221-1230, Case 30-2023, 2023

A Young Adult Man with Cognitive Changes, Gait Difficulty, and Renal Insufficiency
Neurol 100:206-212, Stamm,B.,et al, 2023

Babesiosis: Clinical Manifgestations and Diagnosis
www.UptoDate.com, Oct, Krause,P.J. & Vannier,E.G., 2022

Hemiparesis and Facial Droop in an Older Woman
BMJ 376:e067134, Anyfantakis, D. & Kastanakis, S., 2022

Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis
Neurol 98:e2368-e2376, Molimard, A.,et al, 2022

A New Option is Approved for Patients with Myasthenia Gravis
JAMA 327:417, Voelker, R., 2022

Thalamus L-Sign: A Potential Biomarker of Neonatal Partial, Prolonged Hypoxic-Ischemic Brain Injury or Hypoglycemic Encephalopathy
AJNR 43:919-925, Misser, S.K.,et al, 2022

Curtain Sign
NEJM 387:e7, Sherman, S.V., 2022

Clinicopathologic Conference, Insulinoma
NEJM 387:356-365, Case 23-2022, 2022

A 71-Year-Old Man Presenting with Acute Onset Dysarthria and Dysphagia
Neurol 96:180-184, Spagni, G.,et al, 2021

Clinicopathologic Conference, Acute human immunodeficiency virus type 1
NEJM 385:641-648, Case 24-2021, 2021



Showing articles 0 to 50 of 3322 Next >>